Clinical Immunization Safety Assessment - Vaccines

Relevant Publications

Investigating the Benefit-Risk Profile of Drugs: From Spontaneous Reporting Systems to Real-World Data for Pharmacovigilance.

Issue Release: 2025

Pharmacokinetic and Environmental Risk Assessment of Prime-2-CoV, a Non-Replicating Orf Virus-Based Vaccine against SARS-CoV-2.

Issue Release: 2024

Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.

Issue Release: 2024

Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines.

Issue Release: 2024

From setbacks to success: lessons from the journey of RSV vaccine development.

Issue Release: 2024

Lessons learned from COVID-19, H1N1, and routine vaccine pharmacovigilance in the United States: a path to a more robust vaccine safety program.

Issue Release: 2024

Obstetric and neonatal outcomes in South Africa.

Issue Release: 2024

Safety pharmacology of human endogenous retrovirus-enveloped baculoviral DNA vaccines against SARS-CoV-2 in Sprague-Dawley rats and beagle dogs.

Issue Release: 2024

A rhesus macaque intragastric challenge model for evaluating the safety, immunogenicity, and efficacy of live-attenuated 1 vaccine candidates.

Issue Release: 2024

Neurological complications of influenza vaccination: navigating the spectrum with a focus on acute disseminated encephalomyelitis (ADEM).

Issue Release: 2024

4CMenB journey to the 10-year anniversary and beyond.

Issue Release: 2024

Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates.

Issue Release: 2024

Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinoma.

Issue Release: 2023

Vaccine safety surveillance in Kenya using GAIA standards: A feasibility assessment of existing national and subnational research and program systems.

Issue Release: 2023

Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial.

Issue Release: 2023

Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network.

Issue Release: 2023

Application of estimand framework in ICH E9 (R1) to vaccine trials.

Issue Release: 2023

The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.

Issue Release: 2023

Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic review and meta-analysis.

Issue Release: 2023

A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine.

Issue Release: 2023

How are Clinical Trials Designed to Assess Efficacy?

What is the Difference Between DTP, DTaP, and Tdap?

What Vaccines are Commonly Administered to Newborns?

Are There Any Contraindications for the DTP Vaccine?

What is the Future of Genetic Engineering in Vaccinology?

What are the Advantages of mRNA Vaccines?

How Can the Public Contribute to Pharmacovigilance?

How Do International Organizations Contribute?

How are Modified Vaccines Developed?

What is Vaccine Administration?

Clinical Immunization Safety Assessment - Vaccines

Relevant Publications

Partnered Content Networks

Relevant Topics